Restless Legs Syndrome – Epidemiology – Mature Markets Data
Clarivate Epidemiology's coverage of restless legs syndrome comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan). We report the prevalence of restless legs syndrome for each country, as well as annualized case counts projected to the national population.
Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets.
Clarivate Epidemiology's restless legs syndrome forecast will answer the following questions:
Of all people with restless legs syndrome, how many in each country across the major mature pharmaceutical markets have been formally diagnosed?
How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of restless legs syndrome over the forecast period?
All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.
In addition to the total number of cases for each forecast year, Clarivate Epidemiology also provides at least 10 years of forecast data for the following restless legs syndrome subpopulations:
By severity (mild, moderate, severe, very severe).
Restless Legs Syndrome - Epidemiology - Mature Markets Data
Introduction
Key Findings
Key Updates
Total Prevalence of Restless Legs Syndrome per 100 Among People of All Ages in 2021 and 2041ttttttttt
Relative Sizes of the Factors Contributing to the Trend in Total Prevalent Cases of Restless Legs Syndrome Over the Next Twenty Yearsttttttttt
Analysis of the Total Prevalent Cases of Restless Legs Syndrome in 2021 by Severityttttttttt
Epidemiology Data
Methods
Total Prevalence
Diagnosed Prevalence
Severity
Reference Materials
Literature Review
Studies Included in the Analysis of Restless Legs Syndrome
Studies Excluded from the Analysis of Restless Legs Syndrome
Risk / Protective Factors
Risk / Protective Factors for Restless Legs Syndrome
Bibliography
Abbreviation Table
Glossary
Vivek Pathania
Narendra Parihar, M.P.H., is a principal epidemiologist at Clarivate. His areas of interest are cancer epidemiology, rare disease epidemiology, and targeted therapies in cancer. A former dentist, he earned his M.P.H. from the Tata Institute of Social Sciences in Mumbai.
